In one cancer therapy, two halves are safer than a whole
COLUMBUS, Ohio – Splitting one type of cancer drug in half and delivering the pieces separately to cancer cells could reduce life-threatening side effects and protect healthy, non-cancerous cells, a new study suggests. The study, published today in the Proceedings of the National Academy of Sciences, suggests that splitting immunotoxins into two inactive and benign…